Skip to main content
Help
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Lockups
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
Analysts
News
Trending
Private Companies
Technical Chart
Fundamental Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
Alebund Pharmaceuticals (Jiangsu) Limited (HKG:9637)
Hong Kong
· Delayed Price · Currency is HKD
Full Chart
Watchlist
Alerts
Compare
28.80
+0.30 (1.05%)
At close: Sep 4, 2026
Overview
Financials
Forecast
Statistics
History
Profile
Chart
Financials
Income Statement
Balance Sheet
Cash Flow
Ratios
Annual
Quarterly
TTM
HKG:9637 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
TTM
Mil
Millions
Data
Data Source
CNY
CNY
More
Download
Full Width
Fiscal Year
TTM
FY 2025
FY 2024
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Revenue
122.6
30.56
6.53
Revenue Growth
-
368.29%
-
Cost of Revenue
23.33
17.11
4.14
Gross Profit
99.27
13.45
2.39
Selling, General & Admin
318.4
287.63
77.28
Research & Development
403.92
372.57
235.37
Operating Expenses
722.32
660.21
312.65
Operating Income
-623.05
-646.76
-310.27
Interest Expense
-49.81
-110.55
-29.38
Interest & Investment Income
3.41
1.43
0.57
Earnings From Equity Investments
-37.39
-2.82
0
Currency Exchange Gain (Loss)
-4.83
-0.13
0.05
Other Non Operating Income (Expenses)
5.95
5.15
3.89
EBT Excluding Unusual Items
-705.71
-753.67
-335.13
Gain (Loss) on Sale of Investments
1.1
1.95
-
Gain (Loss) on Sale of Assets
-0.1
-0.1
-0
Pretax Income
-704.71
-751.82
-335.13
Earnings From Continuing Operations
-704.71
-751.82
-335.13
Minority Interest in Earnings
0.9
1.78
9.1
Net Income
-703.81
-750.04
-326.03
Net Income to Common
-703.81
-750.04
-326.03
Net Income Growth
-
-
-
Shares Outstanding (Basic)
272
244
272
Shares Outstanding (Diluted)
272
244
272
Shares Change
-
-10.08%
-
EPS (Basic)
-2.58
-3.07
-1.20
EPS (Diluted)
-2.58
-3.07
-1.20
EPS Growth
-
-
-
Additional Metrics
TTM
Mil
Millions
Data
Data Source
CNY
CNY
More
Download
Full Width
Fiscal Year
TTM
FY 2025
FY 2024
Period Ending
Jun '26
Jun 30, 2026
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Free Cash Flow
-
-389.51
-480.52
Free Cash Flow Per Share
-
-1.59
-1.77
Gross Margin
80.97%
44.00%
36.55%
Operating Margin
-508.18%
-2116.64%
-4755.03%
Profit Margin
-574.05%
-2454.63%
-4996.57%
Free Cash Flow Margin
-
-1274.74%
-7364.34%
EBITDA
-567.15
-607.19
-303.36
D&A For EBITDA
55.9
39.57
6.91
EBIT
-623.05
-646.76
-310.27